Zai Lab Limited
HKEX:9688.HK
23.6 (HKD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 398.988 | 266.719 | 215.04 | 144.312 | 48.958 | 12.985 | 0.129 | 0 | 0 | 0 |
| Cost of Revenue
| 147.86 | 95.816 | 74.018 | 52.239 | 16.736 | 3.749 | 0.044 | 0 | 0 | 0 |
| Gross Profit
| 251.128 | 170.903 | 141.022 | 92.073 | 32.222 | 9.236 | 0.086 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.629 | 0.641 | 0.656 | 0.638 | 0.658 | 0.711 | 0.663 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 234.504 | 265.868 | 286.408 | 573.306 | 222.711 | 142.221 | 120.278 | 39.342 | 32.149 | 13.587 |
| General & Administrative Expenses
| 298.741 | 281.608 | 258.971 | 218.831 | 111.312 | 70.211 | 0 | 12.05 | 6.38 | 2.762 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| SG&A
| 298.741 | 281.608 | 258.971 | 218.831 | 111.312 | 70.211 | 21.576 | 12.05 | 6.38 | 2.762 |
| Other Expenses
| 0 | -10 | 3.113 | -5.54 | 29.076 | 0.938 | 0.059 | 0.529 | 2.534 | 0.303 |
| Operating Expenses
| 533.245 | 537.476 | 545.379 | 792.137 | 334.023 | 212.432 | 141.854 | 51.391 | 38.529 | 16.349 |
| Operating Income
| -282.117 | -366.573 | -404.357 | -700.064 | -301.801 | -203.196 | -141.768 | -51.391 | -38.529 | -16.349 |
| Operating Income Ratio
| -0.707 | -1.374 | -1.88 | -4.851 | -6.164 | -15.649 | -1,095.14 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 25.014 | 31.953 | -38.708 | -3.35 | 34.015 | 8.877 | 3.28 | 1.007 | 1.017 | -1.672 |
| Income Before Tax
| -257.103 | -334.62 | -443.065 | -703.414 | -267.786 | -194.319 | -138.488 | -50.135 | -37.512 | -18.022 |
| Income Before Tax Ratio
| -0.644 | -1.255 | -2.06 | -4.874 | -5.47 | -14.965 | -1,069.805 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 38.929 | -10.97 | 30.376 | -10.953 | 3.319 | -0.478 | 1.517 | 1.975 |
| Net Income
| -257.103 | -334.62 | -481.994 | -692.444 | -298.162 | -183.366 | -139.075 | -50.384 | -37.512 | -18.022 |
| Net Income Ratio
| -0.644 | -1.255 | -2.241 | -4.798 | -6.09 | -14.122 | -1,074.336 | 0 | 0 | 0 |
| EPS
| -0.26 | -3.46 | -4.63 | -7.58 | -3.46 | -3.03 | -2.64 | -2.32 | -3.97 | -2.07 |
| EPS Diluted
| -0.26 | -3.46 | -4.63 | -7.58 | -3.46 | -3.03 | -2.64 | -2.32 | -3.97 | -2.07 |
| EBITDA
| -242.993 | -365.111 | -384.659 | -689.464 | -262.965 | -199.43 | -138.449 | -50.843 | -38.33 | -16.223 |
| EBITDA Ratio
| -0.609 | -1.369 | -1.789 | -4.778 | -5.371 | -15.359 | -1,069.498 | 0 | 0 | 0 |